Skip to main content
SpringerLink
Log in

Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Medication nonadherence is a significant public health problem that affects the health and well-being of older Americans while burdening the US healthcare system. Pharmacy claims data have gained importance in deriving objective medication (re)fill adherence measures; however, little is known about application of such measures in older Americans. The objective of this study was to assess the types and characteristics of pharmacy claims-derived medication (re)fill adherence measures used in older Americans. A comprehensive literature search strategy was employed to identify all articles using pharmacy claims data to measure (re)fill adherence to prescription medications in older Americans aged 65+ years. Included were articles reporting original research studies conducted and published in the USA in English between 1 January 2000 and 1 November 2012. The basic search used multiple key terms indicating adherence, combined with the term “medication” and the term “pharmacy claims or administrative claims.” Due to the variety of measure names used in the literature, a more specific search was added to repeat the basic search for 29 previously used medication (re)fill adherence measure names. Articles identified through the database search were manually reviewed to select only articles meeting the inclusion criteria. The search resulted in a total of 36 articles. Information on medication (re)fill measurements were extracted and summarized. The 36 articles used 20 differently named measures under the three main concepts: medication adherence, persistence, and discontinuation. Measures of medication adherence cumulatively assessed the proportion of time at which medications were (not) filled over a predefined observation period (e.g., medication possession ratio). Measures of medication persistence assessed the continuity of medication filling over a specified time period, while medication discontinuation measures focused on termination of medication (re)fills. Overall, almost two thirds of all identified articles used a single medication (re)fill adherence measure. Among them, 77 % used a medication possession measure. The term “medication possession ratio” (MPR) was used most frequently (65 %), followed by the “proportion of days covered” (PDC; 30 %). No single measure can be generally recommended for the use in older Americans. The challenges in using pharmacy claims-based medication (re)fill adherence measures in older Americans include a lack of consensus terminology and algorithms among measures of the same concepts, insufficient transparency of individual measure operationalization, and inadequate consideration of unique characteristics of the older population, such as temporary nursing home care. Although medication (re)fill adherence measures may be well suited for measuring medication adherence in older Americans, little guidance is available on how to use them in this population. Further efforts need to be given to the development and standardization of pharmacy claims-based medication (re)fill measures that are specifically tailored toward use in older Americans.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. US Census Bureau. Percent distribution of the projected population by selected age groups and sex for the United States: 2010 to 2050. Population Division 2008. http://www.census.gov/population/www/projections/summarytables.html. Accessed 22 November 2012.

  2. Anderson G. Chronic care: making the case for ongoing care. Robert Wood Johnson Foundation, Princeton, NJ. http://www.rwjf.org/files/research/50968chronic.care.chartbook.pdf. Accessed 21 November 2012.

  3. Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. NCHS Data Brief 2010. http://www.cdc.gov/nchs/data/databriefs/db42.pdf. Accessed 22 November 2012.

  4. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.

    Article  PubMed  Google Scholar 

  5. Sabaté E. Adherence to long-term therapies: evidence for action. 2003. http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf. Accessed 20 November 2012.

  6. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25(11):2958–71.

    Article  PubMed  Google Scholar 

  7. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

    Article  PubMed  CAS  Google Scholar 

  8. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drug Aging. 2004;21(12):793–811.

    Article  Google Scholar 

  9. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Ann Intern Med. 1990;150(4):841–5.

    Article  CAS  Google Scholar 

  10. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–9.

    CAS  Google Scholar 

  11. Touchette DR, Burns AL, Bough MA, et al. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc. 2006;46(6):683–91.

    Article  Google Scholar 

  12. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.

    Article  PubMed  CAS  Google Scholar 

  13. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565–74.

    Article  PubMed  Google Scholar 

  14. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280–8.

    Article  PubMed  Google Scholar 

  15. Karve S, Cleves MA, Helm M, et al. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46(11):1125–33.

    Article  PubMed  Google Scholar 

  16. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care. 2005;11(7):453–60.

    Google Scholar 

  17. Steiner JF, Prochazka AV. The assessment of (re)fill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105–16.

    Article  PubMed  CAS  Google Scholar 

  18. Steiner JF, Koepsell TD, Fihn SD, et al. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988;26(8):814–23.

    Article  PubMed  CAS  Google Scholar 

  19. Balkrishnan R, Bhosle MJ, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: A longitudinal cohort study. J Urol. 2006;175(3):1067–72.

    Article  PubMed  Google Scholar 

  20. Krousel-Wood M, Islam T, Webber LS, et al. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.

    PubMed  Google Scholar 

  21. Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10(1):3–12.

    Article  PubMed  Google Scholar 

  22. Ebbert JO, Dupras DM, Erwin PJ. Concise review for clinicians: searching the medical literature using PubMed: a tutorial. Mayo Clin Proc. 2003;78(1):87–91.

    Article  PubMed  Google Scholar 

  23. Barcenas CH, Zhang N, Zhao H, et al. Anthracycline regimen adherence in older patients with early breast cancer. Oncologist. 2012;17(3):303–11.

    Article  PubMed  CAS  Google Scholar 

  24. Conwell LJ, Esposito D, Garavaglia S, et al. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis. Am J Geriatr Pharmacother. 2011;9(4):241–9.

    Article  PubMed  Google Scholar 

  25. Curtis JR, Yun H, Matthews R, et al. Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare population. Arthritis Care Res. 2012;64(7):1054–60.

    CAS  Google Scholar 

  26. Donohue JM, Zhang Y, Aiju M, et al. Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression. Am J Geriatr Psychiatry. 2011;19(12):989–97.

    Article  PubMed  Google Scholar 

  27. Ettinger AB, Manjunath R, Candrilli SD, et al. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav. 2009;14(2):324–9.

    Article  PubMed  Google Scholar 

  28. Holmes HM, Luo R, Hanlon JT, et al. Ethnic disparities in adherence to antihypertensive medications of Medicare Part D beneficiaries. J Am Geriatr Soc. 2012;60(7):1298–303.

    Article  PubMed  Google Scholar 

  29. Jung K, McBean AM, Kim JA. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs. J Manag Care Pharm. 2012;18(2):106–15.

    PubMed  Google Scholar 

  30. Kulik A, Shrank WH, Levin R, et al. Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am J Cardiol. 2011;107(10):1409–14.

    Article  PubMed  Google Scholar 

  31. Li P, McElligott S, Bergquist H, et al. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med. 2012;156(11):776–84.

    Article  PubMed  Google Scholar 

  32. Patrick AR, Brookhart MA, Losina E, et al. The complex relation between bisphosphonate adherence and fracture reduction. J Clin Endocrinol Metab. 2010;95(7):3251–9.

    Article  PubMed  CAS  Google Scholar 

  33. Patrick AR, Schousboe JT, Losina E, et al. The economics of improving medication adherence in osteoporosis: validation and application of a simulation Model. J Clin Endocrinol Metab. 2011;96(9):2762–70.

    Article  PubMed  CAS  Google Scholar 

  34. Poon I, Lal LS, Ford ME, et al. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother. 2009;43(2):185–93.

    PubMed  Google Scholar 

  35. Setoguchi S, Choudhry NK, Levin R, et al. Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure. Clin Pharmacol Ther. 2010;88(4):548–54.

    Article  PubMed  CAS  Google Scholar 

  36. Solomon DH, Iversen MD, Avorn J, et al. Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med. 2012;172(6):477–83.

    Article  PubMed  Google Scholar 

  37. Stuart B, Simoni-Wastila L, Yin X, et al. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans. Med Care. 2011;49(5):511–5.

    Article  PubMed  Google Scholar 

  38. Swindle JP, Potash J, Kulakodlu M, et al. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin. Am J Geriatr Pharmacother. 2011;9(6):471–82.

    Article  PubMed  CAS  Google Scholar 

  39. Yang Y, Thumula V, Pace PF, et al. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs. J Am Pharm Assoc. 2010;50(4):527–31.

    Article  Google Scholar 

  40. Zeber JE, Copeland LA, Pugh MJV. Variation in antiepileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother. 2010;44(12):1896–904.

    Article  PubMed  Google Scholar 

  41. Balkrishnan R, Christensen DB. A comparison of medication adherence indices to assess long-term inhaled corticosteroid medication use. J Asthma. 2001;38(1):91–8.

    Article  PubMed  CAS  Google Scholar 

  42. Bhosle MJ, Reardon G, Camacho FT, et al. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population. Am J Geriatr Pharmacother. 2007;5(2):100–11.

    Article  PubMed  Google Scholar 

  43. Chapman RH, Petrilla AA, Benner JS, et al. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drug Aging. 2008;25(10):885–92.

    Article  Google Scholar 

  44. Choudhry NK, Setoguchi S, Levin R, et al. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008;17(12):1189–96.

    Article  PubMed  Google Scholar 

  45. Dickson M, Plauschinat CA. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Am J Cardiovasc Drugs. 2008;8(1):45–50.

    Article  PubMed  CAS  Google Scholar 

  46. Huskamp HA, Deverka PA, Landrum MB, et al. The effect of three-tier formulary adoption on medication continuation and spending among elderly retirees. Health Serv Res. 2007;42(5):1926–42.

    Article  PubMed  Google Scholar 

  47. Jayawant SS, Bhosle MJ, Anderson RT, et al. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma. J Glaucoma. 2007;16(6):513–20.

    Article  PubMed  Google Scholar 

  48. Keene MS, Eaddy MT, Nelson WW, et al. Adherence to paroxetine CR compared with paroxetine IR in a Medicare-eligible population with anxiety disorders. Am J Manag Care. 2005;11(Suppl. 12):S362–9.

    PubMed  Google Scholar 

  49. Kulkarni AS, Balkrishnan R, Anderson RT, et al. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson’s disease. Mov Disord. 2008;23(3):359–65.

    Article  PubMed  Google Scholar 

  50. Mucha L, Shaohung S, Cuffel B, et al. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer’s disease. J Manag Care Pharm. 2008;14(5):451–61.

    PubMed  Google Scholar 

  51. Winkelmayer WC, Levin R, Setoguchi S. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol. 2008;3(5):1415–22.

    Article  PubMed  Google Scholar 

  52. Donohue JM, Zhang Y, Lave JR, et al. The Medicare drug benefit (Part D) and treatment of heart failure in older adults. Am Heart J. 2010;160(1):159–65.

    Article  PubMed  Google Scholar 

  53. Curtis JR, Westfall AO, Cheng H, et al. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. Osteoporos Int. 2009;20(6):973–8.

    Article  PubMed  CAS  Google Scholar 

  54. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Arch Intern Med. 2005;165(20):2414–9.

    Article  PubMed  Google Scholar 

  55. Roe CM, Anderson MJ, Spivack B. How many patients complete an adequate trial of donepezil? Alz Dis Assoc Dis. 2002;16(1):49–51.

    Article  Google Scholar 

  56. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23.

    Article  PubMed  Google Scholar 

  57. Martin BC, Wiley-Exley EK, Richards S, et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009;43(1):36–44.

    Article  PubMed  Google Scholar 

  58. Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009;15(7):457–64.

    PubMed  Google Scholar 

  59. Jacobson G, Neuman T, Damico A, et al. Medicare Advantage plan star ratings and bonus payments in 2012. The Kaiser Family Foundation 2011. http://www.kff.org/medicare/upload/8257.pdf. Accessed 29 November 2012.

  60. Centers for Medicare and Medicaid Services. Medicare health & drug plan quality and performance ratings 2012 Part C and Part D technical notes - first plan preview draft 2011. http://www.calquality.org/documents/Technical_Notes_2012.pdf. Accessed 29 November 2012.

  61. Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence: Pharmacy Quality Alliance 2011. http://www.pqaalliance.org/files/PDCvsMPRfinal.pdf. Accessed 30 November 2012.

  62. Dezii CM. Persistence with drug therapy: a practical approach using administrative claims data. Manag Care. 2001;10(2):42.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by the University of Georgia FACS Faculty Research Award. There is no conflict of interest for any of the authors concerning the content of this manuscript.

Author information

Authors and Affiliations

  1. Department of Foods and Nutrition, University of Georgia, 280 Dawson Hall, Athens, GA, 30602, USA

    Elisabeth Lilian Pia Sattler & Jung Sun Lee

  2. College of Pharmacy, University of Georgia, Athens, GA, 30602, USA

    Matthew Perri III

Authors
  1. Elisabeth Lilian Pia Sattler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jung Sun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthew Perri III
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jung Sun Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sattler, E.L.P., Lee, J.S. & Perri, M. Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature. Drugs Aging 30, 383–399 (2013). https://doi.org/10.1007/s40266-013-0074-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-013-0074-z

Keywords

Search

Navigation